Lenzilumab (Anti-CSF2 / GM-CSF)

Lenzilumab (Anti-CSF2 / GM-CSF) is a recombinant monoclonal antibody against the cytokine granulocyte macrophage colony-stimulating factor (GM-CSF), with potential immunomodulating activity. MW: 145.72 KD.

• Supplier: Selleck Chemicals
• Product #: A2854
• Sku #: A2854-1mg